Australia markets open in 6 hours 10 minutes

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.85+0.15 (+1.55%)
As of 01:47PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 90.86M
Enterprise value 77.08M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.12k
Price/book (mrq)7.90
Enterprise value/revenue 11.01k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3181.08%
S&P500 52-week change 323.23%
52-week high 310.88
52-week low 31.86
50-day moving average 38.32
200-day moving average 35.20

Share statistics

Avg vol (3-month) 346.16k
Avg vol (10-day) 335.59k
Shares outstanding 59.37M
Implied shares outstanding 69.37M
Float 86.01M
% held by insiders 19.28%
% held by institutions 165.22%
Shares short (28 June 2024) 492.27k
Short ratio (28 June 2024) 41.89
Short % of float (28 June 2024) 41.06%
Short % of shares outstanding (28 June 2024) 40.99%
Shares short (prior month 31 May 2024) 412.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 326 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-307,028.56%

Management effectiveness

Return on assets (ttm)-115.70%
Return on equity (ttm)-267.59%

Income statement

Revenue (ttm)7k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.41M
Net income avi to common (ttm)-21.69M
Diluted EPS (ttm)-9.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.14M
Total cash per share (mrq)1.51
Total debt (mrq)354k
Total debt/equity (mrq)3.08%
Current ratio (mrq)4.18
Book value per share (mrq)4.22

Cash flow statement

Operating cash flow (ttm)-20.2M
Levered free cash flow (ttm)-11.91M